youtube_live
Q2 2027 earnings • in 1 day
See detailschevron_right
4568:TYO
Daiichi Sankyo Co Ltd
Â¥2,580.00
arrow_downward
-0.56%(-14.50) 1D
Oct 28, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4568...
Open
Â¥2,644
High
Â¥2,666
Low
Â¥2,571
Mkt. cap
4.81T
Avg. vol.
6.85M
Volume
8.77M
Dividend
3.02%
Quarterly dividend
Â¥19
P/E ratio
19.54
52-wk high
Â¥4,066
52-wk low
Â¥2,390
EPS
Â¥132
Shares outstanding
647.77M
No. of employees
20K
Open
Â¥2,644
High
Â¥2,666
Low
Â¥2,571
Mkt. cap
4.81T
Avg. vol.
6.85M
Volume
8.77M
Dividend
3.02%
Quarterly dividend
Â¥19
P/E ratio
19.54
52-wk high
Â¥4,066
52-wk low
Â¥2,390
EPS
Â¥132
Shares outstanding
647.77M
No. of employees
20K
News stories
From web sources and news partners
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd
CEOHiroyuki Okuzawa
Employees20.2K
FoundedSep 28, 2005
HeadquartersChuo City, Tokyo, Japan
Sector-
Websitedaiichisankyo.co.jp